Host Angiotensin Receptor and its role in Covid-19 Infection

Apr 30, 2021- by CMI| Category : Biotechnology1 min read
Host Angiotensin Receptor and its role in Covid-19 Infection

 

After emerging first in December 2019, novel coronavirus, ravaged whole world with pandemic being imposed.

The virus got transmitted in every continent in a community scale except Antarctica. SARS-Cov-2, the virus was thought to be inconsequential entity, which circulates in the nature with the help of various host and other intermediate species, thereby occasionally infecting the humans. It was also thought that the infection of this virus is only limited in the upper respiratory tract in a mild state. However, the pathogenesis of Covid-19 is somewhat different and it’s characterized by a novel spike protein, extremely prone to mutation. Thus, along with respirator disorder it also results in Heart, Liver, and Kidney damage.

The SARS-Cov-2 interact with angiotensin receptor of the host cell with its own glycoprotein spike. The receptor is named as Angiotensin Converting Enzyme 2 (ACE2). This association helps the virus to enter in to the host cell crossing the cell membrane. This ACE2 receptor is widely distributed in different area of the body like endothelium layer of arteries and veins, alveolar cells of human lungs, in few enterocytes and also in parts of the CNS (Central Nervous System). ACE2 in particular scientific study is found to be the SARS-Cov-2 receptor. And thereby ACE2 is providing a specific link between inflammation, immunity and other symptoms of this disease. The difference in the amino-acid residue of the receptor-binding protein of human ACE2 receptor is the reason of its building ability to the human host cell, which will also add to the increased pathogenesis of SARS-Cov-2.

Thereby it can be concluded that ACE2 can protect intense lung infection. Although it can also act as a facilitator for the virus to get entry in to the epithelial layer of the lungs, therefore acting as the major site for different therapeutic interventions. Although an ongoing debate is present whether ACE2 increase viral susceptibility in the patient’s body, or inhibiting the receptor can hold the viral infection as a whole. Proper targeted mechanism will always be helpful for proper clinical outcome.

Share this story

About the author

Ravina Pandya

is a seasoned content writer with over 3.5 years of hands-on experience across various writing formats, including news articles, blog posts, press releases, and informational content. Her expertise lies in producing high-quality, informative content tailored to meet the specific needs of diverse industries, such as Biotechnology, Clinical Diagnostic, Healthcare IT, advanced material, and Medical Devices. She has a deep understanding of how to craft engaging narratives that align with industry trends, helping businesses enhance their online presence and communicate effectively with their audiences.

What sets Ravina apart is her keen eye for detail and her passion for storytelling. She approaches every piece of content with the intent to make it not just informative but also impactful, ensuring that it resonates with the audience on a deeper level. With a reputation for producing timely and relevant articles, she has made significant contributions to the field by helping companies effectively communicate their brand message through engaging, clear, and creative writing. As an advocate for clarity in communication, she continues to explore new ways of refining her craft while remaining at the forefront of content trends.